Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215)

British Journal of Pharmacology

Volumn 149, Issue 7, 2006, Pages 888-897

  Sakurai, T ^a   Kojima, C ^a   Kobayashi, Y ^b   Hirano, S ^b   Sakurai, M H ^c   Waalkes, M P ^d   Himeno, S ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^c AZABU UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acute promyelocytic leukemia; Arsenic; Arsenite; Dimethylarsenic; Dimethylarsinic acid; Dimethylarsinous glutathione; GSH; Methylation; Trivalent dimethylarsenic; Trivalent methylarsenic

Indexed keywords

ARSENIC DERIVATIVE; CACODYLIC ACID; DIMETHYLARSINOUS GLUTATHIONE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; HUMAN SERUM ALBUMIN; ORGANIC COMPOUND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG PURIFICATION; DRUG SYNTHESIS; DRUG TRANSPORT; ERYTHROCYTE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; LC 50; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM;

ANIMALS; ANTINEOPLASTIC AGENTS; ARSENIC POISONING; ARSENICALS; ARSENITES; CACODYLIC ACID; CELL LINE; CELL SURVIVAL; CHROMATOGRAPHY, THIN LAYER; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GLUTATHIONE; HEPATOCYTES; HUMANS; INHIBITORY CONCENTRATION 50; METHYLATION; RATS; RATS, INBRED F344; SERUM ALBUMIN; TIME FACTORS;

EID: 33845228913     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706899     Document Type: Article

References (32)

1. Buchet JP, Lauwerys R, Roels H (1980). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48: 71-79.
2. 3 exerts dose-dependent dual effects on APL cells. Blood 89: 3345-3353.
3. De Flora S, Izzotti A, D'Agostini F, Balansky RM (2001). Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22: 999-1013.
4. Donner MG, Klein GK, Mathes PB, Schwandt P, Richter WO (1998). Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile. Metaboism 47: 273-279.
5. Dopp E, Hartmann LM, Florea AM, von Recklinghauesn U, Pieper R, Shokouhi B et al. (2004). Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol Appl Pharmacol 201: 156-165.
6. Dopp E, Hartmann LM, von Recklinghauesn U, Florea AM, Rabieh S, Zimmermann U et al. (2005). Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells. Toxicol Sci 87: 46-56.
7. Fukai Y, Hirata M, Ueno M, Ichikawa N, Kobayashi H, Saitoh H et al. (2006). Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine. Biol Pharm Bull 29: 1022-1027.
8. Hayakawa T, Kobayashi Y, Cui X, Hirano S (2005). A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79: 183-191.
9. Hindmarsh JT, McCurdy F (1986). Clinical and environmental aspects of arsenic toxicity. Crit Rev Clin Lab Sci 23: 315-347.
10. Idoine JB, Elliott JM, Wilson MJ, Weisburger EK (1976). Rat liver cells in culture: effect of storage, long-term culture, and transformation on some enzyme levels. In Vitro 12: 541-553.
11. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS et al. (2000). The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275: 33404-33408.
12. Kokcam I, Naziroglu M (1999). Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 289: 23-31.
13. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ et al. (2001). Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14: 355-361.
14. Mizoguchi H, Hara S (1996). Effect of fatty acid saturation in membrane lipid bilayers on simple diffusion in the presence of ethanol at high concentrations. J Ferment Bioeng 81: 406-411.
15. Morton WE, Dunnette DA (1994). Health effects of environmental arsenic. In: Nriagu JO (ed). Arsenic in the Environment Vol. II. John Wiley & Sons, New York, pp 17-34.
16. NRC (1999). Arsenic in the Drinking Water. National Research Council, National Academy Press, Washington, DC.
17. Ohta T, Sakurai T, Fujiwata K (2004). Effects of arsenobetaine, a major organic arsenic compound in seafood, on the maturation and functions of human peripheral blood monocytes, macrophages and dendritic cells. Appl Organomet Chem 18: 431-437.
18. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H et al. (2000). Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 28: 1137-1142.
19. Sakurai T, Kaise T, Matsubara C (1998). Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem Res Toxicol 11: 273-283.
20. Sakurai T, Kojima C, Ochiai M, Ohta T, Sakurai MH, Waalkes MP et al. (2004a). Cellular glutathione prevents cytolethality of monomethylarsonic acid. Toxicol Appl Pharmacol 195: 129-141.
21. Sakurai T, Ochiai M, Kojima C, Ohta T, Sakurai MH, Takada NO et al. (2004b). Role of glutathione in dimethylarsinic acid-induced apoptosis. Toxicol Appl Pharmacol 198: 354-365.
22. Sakurai T, Ochiai M, Kojima C, Ohta T, Sakurai MH, Takada NO et al. (2005). Preventive mechanism of cellular glutathione in monomethylarsonic acid-induced cytolethality. Toxicol Appl Pharmacol 206: 54-65.
23. Sakurai T, Qu W, Sakurai MH, Waalkes MP (2002). A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis. Chem Res Toxicol 15: 629-637.
24. Scott N, Hatlelid KM, Mackenzie NE, Carter DE (1993). Reactions of arsenic (III) and arsenic (V) species with glutathione. Chem Res Toxicol 6: 102-106.
25. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY et al. (1997). Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360.
26. Shraim A, Hirano S, Yamauchi H (2001). Extraction and speciation of arsenic in hair using HPLC-ICP MS. Anal Sci 17 (Suppl): i1729-i1732.
27. Styblo M, Del Razo LM, Vega L, Germolec DR, Lecluyse EL, Hamilton GA et al. (2000). Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rats and human cells. Arch Toxicol 74: 289-299.
28. Thompson DJ (1993). A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact 88: 89-114.
29. Wang Z, Zhou J, Lu X, Gong Z, Le XC (2004). Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chem Res Toxicol 17: 95-103.
30. Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC (2003). Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 111: 1429-1438.
31. Yamauchi H, Yamamura Y (1979). Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Ind Health 17: 79-83.
32. V) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14: 1051-1057.